Article
Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
American journal of kidney diseases : the official journal of the National Kidney Foundation - 1 Apr 2010
Davin Jean-Claude, Gracchi Valentina, Bouts Antonia, Groothoff Jaap, Strain Lisa, Goodship Tim
Abstract excerpt
Kidney transplant in patients with atypical hemolytic uremic syndrome (aHUS) is associated with a poor outcome because of recurrent disease, especially in patients known to have a factor H mutation. Long-term prophylactic plasma exchange and combined liver-kidney transplant have prevented graft l...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.